 |
PDBsum entry 3e8l
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase inhibitor/hydrolase
|
PDB id
|
|
|
|
3e8l
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.3.4.21.4
- trypsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Xaa, Lys-|-Xaa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Biol Chem
284:26676-26684
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
The ternary structure of the double-headed arrowhead protease inhibitor API-A complexed with two trypsins reveals a novel reactive site conformation.
|
|
R.Bao,
C.Z.Zhou,
C.Jiang,
S.X.Lin,
C.W.Chi,
Y.Chen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The double-headed arrowhead protease inhibitors API-A and -B from the tubers of
Sagittaria sagittifolia (Linn) feature two distinct reactive sites, unlike other
members of their family. Although the two inhibitors have been extensively
characterized, the identities of the two P1 residues in both API-A and -B remain
controversial. The crystal structure of a ternary complex at 2.48 A resolution
revealed that the two trypsins bind on opposite sides of API-A and are 34 A
apart. The overall fold of API-A belongs to the beta-trefoil fold and resembles
that of the soybean Kunitz-type trypsin inhibitors. The two P1 residues were
unambiguously assigned as Leu(87) and Lys(145), and their identities were
further confirmed by site-directed mutagenesis. Reactive site 1, composed of
residues P5 Met(83) to P5' Ala(92), adopts a novel conformation with the Leu(87)
completely embedded in the S1 pocket even though it is an unfavorable P1 residue
for trypsin. Reactive site 2, consisting of residues P5 Cys(141) to P5'
Glu(150), binds trypsin in the classic mode by employing a two-disulfide-bonded
loop. Analysis of the two binding interfaces sheds light on atomic details of
the inhibitor specificity and also promises potential improvements in enzyme
activity by engineering of the reactive sites.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|